Earnings Data
Report Date
Nov 04, 2026TBA (Confirmed)
Period Ending
2026 (Q3)Consensus EPS Forecast
-0.85Last Year’s EPS
-0.95Same Quarter Last Year
Moderate Buy
Based on 14 Analysts Ratings
CH:1CG Q2 2026 Earnings Report
CH:1CG Upcoming Earnings
Crispr Therapeutics AG's next earnings date is estimated for November 4, 2026, based on past reporting schedules.
CH:1CG Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
CH:1CG Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 03, 2026 | CHF39.10 | CHF39.10 | 0.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Crispr Therapeutics AG (CH:1CG) report earnings?
Crispr Therapeutics AG (CH:1CG) is schdueled to report earning on Nov 04, 2026, TBA (Confirmed).
What is Crispr Therapeutics AG (CH:1CG) earnings time?
Crispr Therapeutics AG (CH:1CG) earnings time is at Nov 04, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Crispr Therapeutics AG stock?
The P/E ratio of Crispr Therapeutics AG is N/A.
What is CH:1CG EPS forecast?
CH:1CG EPS forecast for the fiscal quarter 2026 (Q3) is -0.85.
